Related Experiment Video

Updated: May 29, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Diffuse alveolar damage in patients with dermatomyositis: a six-case series

Yuko Matsuki1, Hiroyuki Yamashita, Yuko Takahashi

  • 1Division of Rheumatic Diseases, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku, Tokyo 162-8655, Japan. matsuki-y@ncchd.go.jp

Modern Rheumatology
|September 10, 2011
PubMed

Insights

Early intravenous pulse cyclophosphamide (IVCY) may benefit patients with dermatomyositis (DM) and interstitial pneumonia. Prompt treatment is crucial for diffuse alveolar damage (DAD) in DM, especially with elevated ferritin or KL-6 levels.

Area of Science:

  • Pulmonology
  • Rheumatology
  • Pathology

Background:

  • Dermatomyositis (DM) can present with severe myopathy or clinically amyopathic DM (CADM).
  • Interstitial pneumonia is a serious complication of DM, potentially leading to diffuse alveolar damage (DAD).

Observation:

  • Six cases of DM with DAD were analyzed over 8 years.
  • DAD developed shortly after DM onset in all patients.
  • Five patients with DAD did not respond to standard therapies like steroids, cyclosporine, or tacrolimus.

Findings:

  • Elevated serum Krebs von der Lungen-6 (KL-6) and ferritin levels may predict lethal DAD.
  • Early intravenous pulse cyclophosphamide (IVCY) therapy was associated with survival in one CADM patient.
  • Delayed IVCY was ineffective for advanced DAD.

Implications:

  • Prompt initiation of IVCY therapy may be beneficial for DM patients with interstitial pneumonia and elevated biomarkers (ferritin, KL-6).
  • Early detection and intervention are critical for managing DAD in DM.
  • This suggests a potential therapeutic window for IVCY in specific DM-associated lung conditions.

More Related Videos

Granulocyte-dependent Autoantibody-induced Skin Blistering12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Refined Murine Model of Idiopathic Pulmonary Fibrosis07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...